Customised targeted massively parallel sequencing enables more precise diagnosis of patients with epilepsy

Abstract

NGS-based testing panels contribute to the diagnosis of epilepsy and might change the clinical management by preventing unnecessary and potentially harmful diagnostic procedures and management in patients. Thus, our results highlight the benefit of genetic testing in children suffering with epilepsy.